BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29935384)

  • 1. Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?
    Rossi JG; Rubio P; Alonso CN; Bernasconi AR; Sajaroff EO; Digiorge J; Baialardo E; Eandi-Eberle S; Guitter M; Fernandez-Barbieri A; Mitchell R; Felice MS
    Leuk Res; 2018 Aug; 71():6-12. PubMed ID: 29935384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
    Cetin N; Lorsbach RB
    Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
    Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
    J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
    Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
    Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
    Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
    Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
    Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
    Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
    Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
    Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.
    Takeuchi S; Sugito S; Uemura Y; Miyagi T; Kubonishi I; Taguchi H; Enzan H; Ohtsuki Y; Miyoshi I
    Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful acute lymphoblastic leukemia-type therapy in two children with mixed-phenotype acute leukemia.
    Otsubo K; Yabe M; Yabe H; Fukumura A; Morimoto T; Kato M; Mochizuki H
    Pediatr Int; 2016 Oct; 58(10):1072-1076. PubMed ID: 27577674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
    Duchayne E; Fenneteau O; Pages MP; Sainty D; Arnoulet C; Dastugue N; Garand R; Flandrin G; ;
    Leuk Lymphoma; 2003 Jan; 44(1):49-58. PubMed ID: 12691142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukemias of ambiguous origin.
    Porwit A; Béné MC
    Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute leukemias of ambiguous lineage.
    Béné MC; Porwit A
    Semin Diagn Pathol; 2012 Feb; 29(1):12-8. PubMed ID: 22372202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
    Bene MC; Castoldi G; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer MB
    Leukemia; 1995 Oct; 9(10):1783-6. PubMed ID: 7564526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
    Azad VF; Mehrvar A; Mehrvar N
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.